Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (AAVXF) Profit After Tax (2023 - 2025)

Historic Profit After Tax for Abivax (AAVXF) over the last 3 years, with Q3 2025 value amounting to -$297.1 million.

  • Abivax's Profit After Tax fell 58985.87% to -$297.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$297.1 million, marking a year-over-year change of. This contributed to the annual value of -$188.3 million for FY2024, which is 1784.49% down from last year.
  • Latest data reveals that Abivax reported Profit After Tax of -$297.1 million as of Q3 2025, which was down 58985.87% from -$114.1 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Profit After Tax ranged from a high of $60.7 million in Q3 2024 and a low of -$334.6 million during Q4 2024
  • In the last 3 years, Abivax's Profit After Tax had a median value of -$36.2 million in 2025 and averaged -$87.6 million.
  • Examining YoY changes over the last 5 years, Abivax's Profit After Tax showed a top increase of 1829.13% in 2025 and a maximum decrease of 58985.87% in 2025.
  • Quarter analysis of 3 years shows Abivax's Profit After Tax stood at -$159.0 million in 2023, then tumbled by 110.48% to -$334.6 million in 2024, then increased by 11.2% to -$297.1 million in 2025.
  • Its Profit After Tax was -$297.1 million in Q3 2025, compared to -$114.1 million in Q2 2025 and $55.1 million in Q1 2025.